These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19749443)

  • 1. The quest for a new vaccine against tuberculosis.
    Delogu G; Fadda G
    J Infect Dev Ctries; 2009 Feb; 3(1):5-15. PubMed ID: 19749443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis vaccine.
    Sarhan MA
    Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of tuberculosis vaccines in clinical trials: Current status.
    Méndez-Samperio P
    Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant live vaccine candidates against tuberculosis.
    Kaufmann SH; Gengenbacher M
    Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Testing of Tuberculosis Vaccine Candidates.
    Hatherill M; Tait D; McShane H
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 28087924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When will the new tuberculosis vaccine appear?].
    Koroliuk AM; Zazimko LA; Petrovskiĭ SV
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):86-94. PubMed ID: 25842959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current challenges and opportunities for bacillus Calmette-Guérin replacement vaccine candidates.
    Méndez-Samperio P
    Scand J Immunol; 2019 Oct; 90(4):e12772. PubMed ID: 31055842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
    Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
    Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens.
    Buddle BM; Pollock JM; Skinner MA; Wedlock DN
    Int J Parasitol; 2003 May; 33(5-6):555-66. PubMed ID: 12782055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
    Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
    J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second Geneva Consensus: Recommendations for novel live TB vaccines.
    Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH
    Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in the development and testing of vaccines against human tuberculosis.
    McMurray DN
    Int J Parasitol; 2003 May; 33(5-6):547-54. PubMed ID: 12782054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle.
    Vordermeier HM; Chambers MA; Buddle BM; Pollock JM; Hewinson RG
    Vet J; 2006 Mar; 171(2):229-44. PubMed ID: 16490705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.
    Dietrich G; Viret JF; Hess J
    Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in tuberculosis vaccine strategies.
    Skeiky YA; Sadoff JC
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.